GEN Exclusives

More »

GEN News Highlights

More »
Mar 12, 2009

BG Medicine, NHLBI, and Boston University Partner for Cardiovascular Biomarker Discovery

  • BG Medicine, the National Heart, Lung, and Blood Institute (NHLBI), and Boston University (BU) will jointly undertake biomarker discovery studies for heart disease and early detection of metabolic syndrome.

    Under this CRADA, BG Medicine's technology will be used to analyze biosamples obtained during years of collection by Framingham Heart Study researchers. The Framingham Heart Study is funded by NHLBI and conducted in collaboration with BU's School of Medicine and School of Public Health.

    Only information from participants who have consented to sharing their specimens and data with commercial researchers will be used, and all shared information will be de-identified to protect participants' privacy.



Related content

Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...
More »

GEN Poll

More » Poll Results »

Ebola Vaccines

When do you think an Ebola vaccine will be available for the general public?